MIR6512

Across TCGA pan-cancer cohorts, MIR6512 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR6512’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MIR6512 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6512 is over-expressed in tumor, although a few such as BRCA and KICH show the opposite, repressed pattern.

LIHC, BRCA, and KICH are the cancer types where MIR6512 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6512 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	II,III,IV	+0.345	<.001	8	view →
BRCA	All	All	−0.304	<.001	6	view →
KICH	Female	II,III,IV	−0.772	.009	4	view →
STAD	Male	II,III,IV	+0.558	.014	3	view →
HNSC	All	All	+0.234	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR6512–LIHC

Open the LIHC breakdown →